Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neoplasm, Residual × aflutinib × 1 year × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 10 NSCLC 4 Meningeal Carcinomatosis 2 Lung Neoplasms 2 Brain Neoplasms 2 Respiratory Tract Neoplasms 1 Non Small Cell Lung Cancer NSCLC 1 Locally Advanced or Metastatic EGFR Sensitising Mutation Positive Non-small Cell Lung Cancer 1 Bronchial Neoplasms 1 Advanced NSCLC Patients With T790M 1 Advanced NSCLC 1 Advanced Lung Cancer 1

Interventions

Cyclophosphamide 11 blinatumomab 8 fludarabine 7 venetoclax 6 fludarabine phosphate 5 Cytarabine 5 Rituximab 4 Lenalidomide 4 Dexamethasone 4 Blood Specimen Collection 4 Azacitidine 4 obinutuzumab 3 daratumumab 3 pembrolizumab 2 nilotinib 2 Vincristine 2 Radiotherapy 2 Methotrexate 2 Melphalan 2 Immunotherapy, Adoptive 2 Imatinib Mesylate 2 Idarubicin 2 Daunorubicin 2 Dasatinib 2 Chemotherapy, Adjuvant 2 trastuzumab deruxtecan 1 tislelizumab 1 tisagenlecleucel 1 thymoglobulin 1 tetrathiomolybdate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡